Authors

Xin Yu
Jin Wang

Publication Date

1-1-2023

Journal

Methods in Enzymology

DOI

10.1016/bs.mie.2022.11.001

PMID

36764757

PMCID

PMC11102804

PubMedCentral® Posted Date

5-19-2024

PubMedCentral® Full Text Version

Author MSS

Published Open-Access

yes

Keywords

Proteolysis, Proteins, Ubiquitin-Protein Ligases, PROTAC, Target Engagement, Nano-BRET, Binding Constant, Relative Intracellular Accumulation Coefficient

Abstract

In recent years, Proteolysis Targeting Chimera (PROTAC) technology has emerged as one of the most promising approaches to remove disease-associated proteins by utilizing cells' own destruction machinery. To achieve successful degradation of a protein of interest (POI), the heterobifunctional PROTAC molecules must penetrate into the cells first, followed by target engagement and formation of the POI-PROTAC-E3 ligase complex. Based on this understanding, the assessment of cell permeability and in cell target engagement are of great importance to evaluate the efficacy of PROTAC candidates. PROTAC molecules can be classified as non-covalent and covalent, and covalent PROTACs can be further divided into irreversible and reversible covalent. Here, we present a high-throughput assay to prioritize different types of BTK PROTACs by measuring their intracellular accumulation quantitatively, using kinase binding assays and the NanoBRET target engagement platform.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.